3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 性质
沸点 | 536.1±40.0 °C(Predicted) |
---|---|
密度 | 1.25±0.1 g/cm3(Predicted) |
储存条件 | 2-8°C |
溶解度 | 在DMSO中的溶解度为20mg/mL,澄清 |
酸度系数(pKa) | 9.33±0.10(Predicted) |
形态 | 粉末 |
颜色 | 白色至浅棕色 |
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 用途与合成方法
IC50: 10 nM (Haspin); 48 nM (DYRK2)
LDN-192960 (10 μM) is selective and inhibits ten of the other kinases by ≥90%, with only five being potently inhibited (IC 50 <1 μM), including CLK1 (IC 50 =0.21 μM), DYRK1A (IC 50 = 0.10 μM), DYRK2 (IC 50 =2 nM), DYRK3 (IC 50 =19 nM) and PIM1 (IC 50 =0.72 μM).LDN-0192960 (0-5 μM; 2 hours) demonstrates that the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells overexpressing Haspin with an EC 50 of 1.17 μM.LDN-0192960 (0-1 μM; 1 hour incubation in the presence of nocodazole and MG132) demonstrates the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells synchronized in mitosis with an EC 50 of 0.02 μM.
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | HY-13455 | 1 mg | 1333 | ||
2024-11-08 | HY-13455 | 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 | 184582-62-5 | 5mg | 2000 |